A targeted network analysis of gene expression profiles of HCT116 p53-null human colon cancer cells treated with ONC201 (18 h and 48 h) revealed that several stem cell-related genes, transcription factors and signaling pathways are significantly modulated by the compound (Fig 1A and S2–S4 Tables). Here, TP53 is linked to malignant colon neoplasm.